Alexandria New Medical Center (EGX:AMES)
Egypt
· Delayed Price · Currency is EGP 21.53
+0.16 (0.75%)
At close: Jun 4, 2025
EGX:AMES Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 386.55 | 353.16 | 277.73 | 261.03 | 275.16 | 225.39 | Upgrade
|
| Revenue Growth (YoY) | 38.52% | 27.16% | 6.40% | -5.13% | 22.08% | 5.48% | Upgrade
|
| Cost of Revenue | 267.58 | 251.61 | 214.54 | 186.87 | 174.17 | 151.71 | Upgrade
|
| Gross Profit | 118.97 | 101.54 | 63.19 | 74.16 | 100.99 | 73.68 | Upgrade
|
| Selling, General & Admin | 66.06 | 61.29 | 48.07 | 50.68 | 32.36 | 29.86 | Upgrade
|
| Other Operating Expenses | -2.87 | -2.37 | 4.9 | 4.74 | 14.55 | -0.01 | Upgrade
|
| Operating Expenses | 73.19 | 68.81 | 53.65 | 63.6 | 53.81 | 38.83 | Upgrade
|
| Operating Income | 45.78 | 32.73 | 9.54 | 10.57 | 47.17 | 34.86 | Upgrade
|
| Interest Expense | - | - | -1.86 | -0.42 | -2.52 | -6.9 | Upgrade
|
| Interest & Investment Income | 7.32 | 8 | 4.81 | 3.98 | 3.58 | 2.48 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.19 | 1.16 | 1.52 | 0.54 | 0 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | 53.28 | 41.89 | 14.01 | 14.66 | 48.23 | 30.42 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -2.83 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.12 | 0.12 | 0.04 | 0.08 | 0.01 | 0.02 | Upgrade
|
| Other Unusual Items | -2.68 | - | - | - | - | - | Upgrade
|
| Pretax Income | 50.73 | 42.01 | 14.04 | 14.74 | 45.41 | 30.44 | Upgrade
|
| Income Tax Expense | 15.02 | 12.2 | 8.11 | 15.44 | 16.86 | 9.59 | Upgrade
|
| Net Income | 35.7 | 29.82 | 5.93 | -0.7 | 28.55 | 20.85 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 1.97 | - | Upgrade
|
| Net Income to Common | 35.7 | 29.82 | 5.93 | -0.7 | 26.58 | 20.85 | Upgrade
|
| Net Income Growth | 10402.95% | 402.63% | - | - | 36.92% | -15.62% | Upgrade
|
| Shares Outstanding (Basic) | 125 | 125 | 125 | 125 | 125 | 125 | Upgrade
|
| Shares Outstanding (Diluted) | 125 | 125 | 125 | 125 | 125 | 125 | Upgrade
|
| Shares Change (YoY) | 3.31% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 0.29 | 0.24 | 0.05 | -0.01 | 0.21 | 0.17 | Upgrade
|
| EPS (Diluted) | 0.29 | 0.24 | 0.05 | -0.01 | 0.21 | 0.17 | Upgrade
|
| EPS Growth | 10066.12% | 402.63% | - | - | 27.47% | -10.73% | Upgrade
|
| Free Cash Flow | -23.05 | -14.13 | -14.97 | -7.4 | 40.68 | 42.38 | Upgrade
|
| Free Cash Flow Per Share | -0.18 | -0.11 | -0.12 | -0.06 | 0.33 | 0.34 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.100 | - | Upgrade
|
| Gross Margin | 30.78% | 28.75% | 22.75% | 28.41% | 36.70% | 32.69% | Upgrade
|
| Operating Margin | 11.84% | 9.27% | 3.44% | 4.05% | 17.14% | 15.47% | Upgrade
|
| Profit Margin | 9.24% | 8.44% | 2.14% | -0.27% | 9.66% | 9.25% | Upgrade
|
| Free Cash Flow Margin | -5.96% | -4.00% | -5.39% | -2.84% | 14.78% | 18.80% | Upgrade
|
| EBITDA | 57.19 | 43.75 | 19.68 | 20.8 | 72.28 | 46.81 | Upgrade
|
| EBITDA Margin | 14.79% | 12.39% | 7.08% | 7.97% | 26.27% | 20.77% | Upgrade
|
| D&A For EBITDA | 11.42 | 11.02 | 10.13 | 10.23 | 25.11 | 11.95 | Upgrade
|
| EBIT | 45.78 | 32.73 | 9.54 | 10.57 | 47.17 | 34.86 | Upgrade
|
| EBIT Margin | 11.84% | 9.27% | 3.44% | 4.05% | 17.14% | 15.47% | Upgrade
|
| Effective Tax Rate | 29.62% | 29.03% | 57.76% | 104.72% | 37.13% | 31.50% | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.